Human antibodies binding to ROR2
US12275789B2 · kind B2 · utility
0Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2022 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | Feb 23, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fully human antibodies and conjugates thereof, which specifically bind to the extracellular domain of receptor tyrosine kinase-like orphan receptor 2 (ROR2).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.